Ledger.Open graph →
SEC Form D · filed May 30, 2012

IRX Therapeutics, Inc

Offering
$1.5M
Sold
$1.5M
Exemption
—
Industry
Biotechnology
Location
New York, NY
Type
—

People & firms on this filing (7)

John W. Hadden · New York, NYDirectorDale S. Okonow · Lexington, MADirectorEric Strasser · San Francisco, CADirectorJohn N. Spencer, Jr · Memphis, TNExec · DirectorJohn C. Pernell, Jr · Johns Island, SCExecJohn T. Spitznagel · New York, NYDirectorDonald Kelly · DALLAS, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗